Ann: Immutep Corporate Presentation, page-34

@RLGphd,

I think it would be good to ask the question of the science team please. I am keen to see what they have to say evenn just now for a response your observation that cd8 figure missed baseline in corporate report, but the figure in poster that includes the baseline seems to suggest cd8 may not be significant. ta.

Here is a slightly more spin: the baseline may not just be a bias diff but may suggest that efti group with higher cd8 at baseline may had already been on the path to produce higher level of cd8 as the disease progressed.